Gordon, K, K Papp, M Gooderman, D Thaci, P Foley, A Morita, S Kundu, R Kisa, A Napoli, and S Banerjee. “Influence of Baseline demographics/Disease Characteristics on Efficacy of an Oral Selective TYK2 Inhibitor, BMS-986165, in Patients With Moderate to Severe Plaque Psoriasis: Phase 2, Randomized, Placebo-Controlled Trial”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S14. Accessed July 23, 2024. https://jofskin.org/33014/index.php/skin/article/view/741.